462 related articles for article (PubMed ID: 16423904)
1. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.
Xu A; Wang Y; Xu JY; Stejskal D; Tam S; Zhang J; Wat NM; Wong WK; Lam KS
Clin Chem; 2006 Mar; 52(3):405-13. PubMed ID: 16423904
[TBL] [Abstract][Full Text] [Related]
2. Circulating adipocyte fatty acid-binding protein, juvenile obesity, and metabolic syndrome.
Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Mierzchala M; Hotowy K; Czapinska E; Kustrzeba-Wojcicka I; Gamian A; Noczynska A
J Pediatr Endocrinol Metab; 2011; 24(11-12):921-8. PubMed ID: 22308843
[TBL] [Abstract][Full Text] [Related]
3. Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children.
Yun KE; Kim SM; Choi KM; Park HS
Metabolism; 2009 Jun; 58(6):798-802. PubMed ID: 19368945
[TBL] [Abstract][Full Text] [Related]
4. Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.
Koh JH; Shin YG; Nam SM; Lee MY; Chung CH; Shin JY
Diabetes Care; 2009 Jan; 32(1):147-52. PubMed ID: 18835952
[TBL] [Abstract][Full Text] [Related]
5. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
6. Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus.
Blaha V; Musil F; Smahelova A; Ticha A; Hyspler R; Haluzik M; Lesna J; Sobotka L
Neuro Endocrinol Lett; 2012; 33 Suppl 2():6-12. PubMed ID: 23183502
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?
Stejskal D; Karpisek M
Eur J Clin Invest; 2006 Sep; 36(9):621-5. PubMed ID: 16919044
[TBL] [Abstract][Full Text] [Related]
8. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity.
Haider DG; Schindler K; Bohdjalian A; Prager G; Luger A; Wolzt M; Ludvik B
Diabetes Obes Metab; 2007 Sep; 9(5):761-3. PubMed ID: 17359244
[TBL] [Abstract][Full Text] [Related]
9. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
10. Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects.
Kim YC; Cho YK; Lee WY; Kim HJ; Park JH; Park DI; Sohn CI; Jeon WK; Kim BI; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Ryu SH
J Nutr Biochem; 2011 Mar; 22(3):289-92. PubMed ID: 20579864
[TBL] [Abstract][Full Text] [Related]
11. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
[TBL] [Abstract][Full Text] [Related]
12. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss.
Stejskal D; Karpisek M; Bronsky J
J Clin Lab Anal; 2008; 22(5):380-2. PubMed ID: 18803274
[TBL] [Abstract][Full Text] [Related]
13. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
[TBL] [Abstract][Full Text] [Related]
14. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment.
Haluzík MM; Anderlová K; Doležalová R; Adamíková A; Haluzíková D; Housová J; Svacina S; Haluzík M
Physiol Res; 2009; 58(1):93-99. PubMed ID: 18198986
[TBL] [Abstract][Full Text] [Related]
15. Association of serum adipocyte fatty acid-binding protein and apolipoprotein B /apolipoprotein A1 ratio with intima media thickness of common carotid artery in dyslipidemic patients.
Orsag J; Karasek D; Halenka M; Vaverkova H; Spurna J; Kubickova V; Lukes J; Zadrazil J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):166-171. PubMed ID: 30209438
[TBL] [Abstract][Full Text] [Related]
16. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
17. PM20D1 is a circulating biomarker closely associated with obesity, insulin resistance and metabolic syndrome.
Yang R; Hu Y; Lee CH; Liu Y; Diaz-Canestro C; Fong CHY; Lin H; Cheng KKY; Pravelil AP; Song E; Lam KSL; Xu A
Eur J Endocrinol; 2021 Dec; 186(2):151-161. PubMed ID: 34757919
[TBL] [Abstract][Full Text] [Related]
18. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis.
Yeung DC; Wang Y; Xu A; Cheung SC; Wat NM; Fong DY; Fong CH; Chau MT; Sham PC; Lam KS
Eur Heart J; 2008 Sep; 29(17):2156-63. PubMed ID: 18603624
[TBL] [Abstract][Full Text] [Related]
19. Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women.
Stefanska A; Sypniewska G; Blaszkiewicz B; Ponikowska I; Cwiklinska-Jurkowska M
Clin Biochem; 2011 Mar; 44(4):304-6. PubMed ID: 21159316
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum adipocyte fatty acid-binding protein and endothelial/hemostatic markers in dyslipidemic subjects.
Karasek D; Vaverkova H; Frysak Z; Orsag J; Novotny D; Halenka M; Slavik L
Neuro Endocrinol Lett; 2012; 33 Suppl 2():26-31. PubMed ID: 23183506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
